ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ALZN Alzamend Neuro Inc

0.945
0.045 (5.00%)
Feb 28 2024 - Closed
Delayed by 15 minutes

Alzamend Neuro Financial Summary

The current ALZN market cap is 6.73M. The company's latest EPS is USD -2.0894 and P/E is -0.44.

Quarter End Oct 2022Jan 2023Apr 2023Jul 2023Oct 2023
USD ($)USD ($)USD ($)USD ($)
Total Revenue 00000
Operating Income -3.11M-5.42M-3.3M-3.53M-2.9M
Net Income -3.11M-5.43M-3.31M-3.53M-2.91M
Year End April 29 2023 2020202120222023
USD ($)USD ($)USD ($)USD ($)
Total Revenue 0000
Operating Income -3.17M-4.95M-12.32M-14.87M
Net Income -3.17M-5.05M-12.36M-14.88M
Quarter End Oct 2022Jan 2023Apr 2023Jul 2023Oct 2023
USD ($)USD ($)USD ($)USD ($)
Total Assets 10.43M8.5M5.92M2.63M984k
Total Liabilities 1.64M2.64M2.87M2.74M3.67M
Total Equity 8.79M5.86M3.05M-113k-2.68M
Year End April 29 2023 2020202120222023
USD ($)USD ($)USD ($)USD ($)
Total Assets 1.81M2.91M14.52M5.92M
Total Liabilities 992k899k1.17M2.87M
Total Equity 822k2.01M13.35M3.05M
Quarter End Oct 2022Jan 2023Apr 2023Jul 2023Oct 2023
USD ($)USD ($)USD ($)USD ($)
Operating -4.88M-6.69M-8.92M-3.3M-4.81M
Investing N/A N/A N/A -147k-147k
Financing N/A N/A N/A N/A 18k
Year End April 29 2023 2020202120222023
USD ($)USD ($)USD ($)USD ($)
Operating -2.15M-2.71M-6.61M-8.92M
Investing 105k101k-106k N/A
Financing 2.29M4.45M18.85M N/A
Market Cap 6.73M
Price to Earnings Ratio -0.44
Price to Sales Ratio 0
Price to Cash Ratio 1.26
Price to Book Ratio 2.13
Dividend Yield -

Share Statistics

Shares Outstanding 7.12M
Average Volume (1 week) 16.16k
Average Volume (1 Month) 19.35k
52 Week Change -88.21%
52 Week High 11.91
52 Week Low 0.74
Spread (Intraday) 0.07 (7.79%)

Company Info

Company Name Alzamend Neuro Inc
Address 251 little falls drive
wilmington, delaware 19808
Website https://www.alzamend.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock